What is Forest Devices?
Forest Devices is a specialized medical device startup dedicated to the development of AlphaStroke, a pioneering diagnostic tool engineered to detect stroke symptoms in any clinical or pre-hospital environment. By focusing on rapid identification, the company addresses a significant gap in emergency medicine, where time-to-treatment is the primary determinant of patient outcomes and long-term disability reduction. The firm operates at the intersection of neurology and portable diagnostic hardware, utilizing advanced sensor technology to provide actionable data to first responders and medical professionals. Its market position is defined by its commitment to clinical efficacy and its strategic integration into the broader healthcare ecosystem, supported by key industry accelerators and institutional backers.
How much funding has Forest Devices raised?
Forest Devices has raised a total of $3.7M across 3 funding rounds:
Debt
$1.3M
Angel/Seed
$2.3M
Debt
$131K
Debt (2017): $1.3M, investors not publicly disclosed
Angel/Seed (2018): $2.3M led by Innovation Works
Debt (2021): $131K supported by PPP
Key Investors in Forest Devices
Innovation Works
A prominent venture development organization that provides capital and operational support to early-stage technology companies in the Pittsburgh region.
Undisclosed Investor
Undisclosed investor participating in the funding round.
PPP
Public-Private Partnership
What's next for Forest Devices?
With the recent infusion of $131K, Forest Devices is well-positioned to accelerate its clinical validation and regulatory pathways. The strategic focus for the upcoming fiscal periods will likely center on scaling the manufacturing of the AlphaStroke device and expanding its footprint within emergency medical services. As the company transitions from a development-heavy startup to a commercial-stage enterprise, the emphasis will shift toward securing broader market adoption and establishing long-term partnerships with hospital networks. The firm's ability to maintain its technological edge while navigating the complex regulatory landscape of the medical device industry will be the primary driver of its future valuation and long-term sustainability in the global health-tech market.
See full Forest Devices company page
